While KRAS is a common oncogene in lung ADC, LKB1/STK11, encoding a serine-threonine kinase implicated in energy sensing and cell polarity, is notable as being among the most commonly mutated tumour suppressors in ADC2. Here, KRAS is linked to neoplasm.